Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 455
Selected: 0
NCT IDTitle
NCT03575806Combine TACE and Autologous Tcm Immunotherapy Versus TACE Alone for HCC With MVI After Radical Resection
NCT05392699ABOD2011 in Patients With Advanced Solid Tumors Progressed After Standard Systemic Therapy
NCT01994213A Study of Famitinib in Patients With Advanced or Metastatic Gastroenteropancreatic Neuroendocrine Tumor
NCT05607225Deep Learning-based Classification and Prediction of Radiation Dermatitis in Head and Neck Patients
NCT06490068Study of LTC004 Combine With Toripalimab in Patient With Solid Tumors Resistant to Immunotherapy
NCT06135571Study on the No.253 Lymph Node Metastasis Patterns in Left-Sided Colon and Rectal Cancer
NCT05944809The Effect of Prophylactic TPO Combined with BMS-IMRT to Esophageal Cancer Patients
NCT05540145Neo-Sequence 1: Neoadjuvant Chemotherapy With or Without Antiangiogenesis and Sequential Immunotherapy for HER2-negative MMR-proficient Locally Advanced Gastric or Gastroesophageal Adenocarcinoma
NCT07046780A Multicenter, Prospective, Non-Interventional Real-World Study of Iparomlimab and Tuvonralimab Injection (QL1706) in the Treatment of Locally Advanced or Metastatic Solid Tumors
NCT06289023HA-WBRT-SIB for Brain Metastasis of Lung Cancer
NCT07083375A Phase II Study of QL1706 With Anti-angiogenesis Therapy and Chemotherapy in Extensive-stage Small Cell Lung Cancer.
NCT03713372Safety and Efficacy of SCT200 in Head and Neck Squamous Cell Carcinoma
NCT05730595Fluorescence Laparoscopic Navigation for Rectal Cancer and Sigmoid Colon Cancer
NCT06342167Efficacy and Safety of Concurrent PD-1 Inhibitor and Radiotherapy With Immunonutrition for Esophageal Squamous Cell Carcinoma
NCT03874871Function Preserving Gastrectomy for T1/2 Gastric Cancer Patients
NCT05443672Multi-center Study of Deep Learning AI in Breast Mass
NCT06773507Phase I Study of BC008-1A Injection in Patients With Advanced Solid Tumors
NCT06889402Prognostic Analysis of Esophageal Cancer with Complete Pathological Response After Neoadjuvant Therapy
NCT05762900Ultra-hypofractioNated Adjuvant Radiotherapy ± sImultaneous Integrated Boost for Low-risk Breast Cancer Patients
NCT05443646Consolidation Serplulimab Following Concurrent Chemoradiotherapy for LS-SCLC Patients
NCT01733589Recombinant Human Endostatin Continued Pumping Into Vein Combining With CCRT in Unresectable Stage III NSCLC
NCT06490341GP Combined With Nimotuzumab and Sintilimab as Induction Therapy for Nasopharyngeal Carcinoma
NCT06653972Efficacy and Safety of a Two-week Dosing Regimen of Vinorelbine Combined with Liposomal Doxorubicin in the Treatment of HER2-negative Advanced Breast Cancer
NCT05497739Intraperitoneal Chemotherapy Guided by the Detection of DNA in Peritoneal Lavage Fluid in Patients With Gastric Cancer
NCT06908668Evaluate the Efficacy and Safety of Adebrelimab Combined With Chemotherapy With or Without Radiotherapy as Neoadjuvant Treatment for HER2-Negative Locally Advanced Breast Cancer
NCT06540508Application of Integrated Proteomic and Serum Metabolomic Analysis in Assessing the Efficacy and Prognosis of TACE Combined With Targeted Immunotherapy in Unresectable Hepatocellular Carcinoma
NCT06416696Toripalimab for High-risk Locally Advanced Cervical Cancer
NCT06761846Sintilimab Combined With Chemotherapy as Adjuvant Treatment for Phase III GC and GEJ
NCT02989259Apatinib for Advanced Non-squamous Head and Neck Cancer
NCT03731442Salvage Chemoradiation Therapy for Recurrence After Radical Surgery or Palliative Surgery in Esophageal Cancer Patients
NCT06897046Perioperative Study of Iparomlimab and Tuvonralimab in Resectable NSCLC
NCT06509919Application of a Novel Biomarker Based on Plasma cfDNA Assay in the Early Diagnosis of Prostate Cancer
NCT0627718068Ga-TCR-FAPI PET/CT Guided Precision Surgery for MTC
NCT05888402Induction Chemotherapy and Toripalimab Followed by Chemoradiotherapy for Large-volume Local Advanced NSCLC
NCT06241079Multi-institutional Analysis of Survival and Recurrence Patterns of Different Pathological Regression Types After Neoadjuvant Chemoradiotherapy or Radiotherapy for Esophageal Squamous Cell Carcinoma
NCT03291574Perioperative Electroacupuncture for Gastric Cancer Patients After Gastrectomy
NCT06761417A Prospective, Single-arm Clinical Study of Liposomal Mitoxantrone Combination Regimen in the Treatment of Relapsed and Refractory Solid Tumors in Children, Adolescents and Young Adults
NCT02765620PERCIST Criteria for Response Evaluation With Solid Tumors
NCT04840355Multi-Centre, Prospective, Non-Interventional Study to Intensively Monitor the Safety of Sintilimab in Clinical Practice Among Chinese Patients
NCT06170697Advanced First-line Treatment of Short-term Postoperative Progression of Head and Neck Squamous Cell Carcinoma
NCT04791176Phase II Study of Concurrent Lenvatinib and Radiotherapy for Advanced HCC
NCT05747326Oral Vinorelbine and Capecitabine in Advanced HER2-negative Breast Cancer
NCT06074484A Study of RC48-ADC Combined With AK104 For Perioperative Treatment of Muscle-Invasive Bladder Cancer
NCT03014102Recombinant Human Thrombopoietin for Mobilization of Peripheral Blood Progenitor Cells for Autologous Transplantation
NCT05761366Application of 18F-PSMA PET / CT Imaging in Prostate Specific Membrane Antigen Positive Tumor
NCT03731754"Cross" Closure for Reconstructing the Perineal Wound of Abdominoperineal Resection
NCT06752148Quantitative Neurofeedback Techniques for Treating Perioperative Cognitive Disorders in Elderly Patients
NCT06842472PD-L1 Inhibitor + RT ± Ursodeoxycholic Acid in Recurrent/Metastatic HER2-Neg Breast Cancer
NCT04074538the National Colorectal Cancer Cohort (NCRCC) Study: National Colorectal Cancer Research Consortium
NCT05815303XELOX Combined With Cadonilimab Versus XELOX as Neoadjuvant Treatment for Locally Advanced, pMMR Rectal Cancer